Can Medical Technology Afford Market Access?

Website header V0_2

Gaining market access for often-life-changing medical technologies remains challenging. Despite companies striving to improve patient care, many still struggle to gain market access, largely for three main reasons: evidence requirements, the reimbursement landscape and undefined value.

Our webinar,  ‘Can Medical Technology Afford Market Access?’, hosted in association with PMGroup, looks at how best to overcome the challenges faced by the sector and discussed potential solutions for gaining successful market access.

Louise Heron, Director, Value Insight & Communication at Adelphi Values, leads this webinar, and is joined by Mark Campbell, Associate Director of the Medical Technologies Evaluation Programme at NICE, and Judith Hargreaves, Director of Healthcare Economics, Policy and Reimbursement at Covidien/Medtronic.

This webinar is useful for professionals working in the pharmaceutical industry including senior market access, pricing and reimbursement, marketing, health economics and outcomes research, value evidence & communication leaders and those involved in commercial aspects of the drug development process.

To watch a recorded version of this free webcast, please follow this link:

Can Medical Technology Afford Market Access?

If you would like further information on this webinar or on any of our broader market access solutions, please contact us or email

Related categories